BNR (Burning Rock Biotech Limited American Depositary Shares) Stock Analysis - Insider Trades

Burning Rock Biotech Limited American Depositary Shares (BNR) is a publicly traded Healthcare sector company. As of May 21, 2026, BNR trades at $17.25 with a market cap of $176.12M and a P/E ratio of 0.00. BNR moved +0.00% today. Year to date, BNR is -31.78%; over the trailing twelve months it is +473.88%. Its 52-week range spans $2.18 to $41.72. Rallies surfaces BNR's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Who is trading BNR stock inside the company?

Recent BNR insider activity includes Han Yusheng bought 314.87K. Rallies tracks insider transaction dates, shares, prices, and estimated values.

BNR Key Metrics

Key financial metrics for BNR
MetricValue
Price$17.25
Market Cap$176.12M
P/E Ratio0.00
EPS$0.00
Dividend Yield0.00%
52-Week High$41.72
52-Week Low$2.18
Volume0
Avg Volume0
Revenue (TTM)$0
Net Income$0
Gross Margin0.00%

Recent BNR Insider Trades

  • Han Yusheng bought 314.87K (~$5.47M) on Mar 31, 2026.

Latest BNR News

BNR Analyst Consensus

BNR analyst coverage data. Average price target: $0.00.

Common questions about BNR

Who is trading BNR stock inside the company?
Recent BNR insider activity includes Han Yusheng bought 314.87K. Rallies tracks insider transaction dates, shares, prices, and estimated values.
Does Rallies show Form 4 insider transactions for BNR?
Yes. Rallies tracks BNR insider trading and Form 4 activity, including executive purchases, executive sales, transaction dates, shares, and prices when available.
Is BNR research on Rallies investment advice?
No. Rallies provides research, data, and educational context for BNR. It does not provide personalized investment advice.
BNR

BNR